ArticleCureus2023

Two Cases of Advanced Hepatocellular Carcinoma Who Responded Well to the Combination of Durvalumab Plus Tremelimumab After Disease Progression During Atezolizumab Plus Bevacizumab Therapy Under Bevacizumab Withdrawal.

Yusuke Kawamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.